SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 297 filers reported holding SEATTLE GENETICS INC in Q2 2018. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $61,179,543,000 | -52.4% | 312,635 | -58.7% | 0.03% | -57.7% |
| Q2 2020 | $128,476,512,000 | +52.2% | 756,100 | +3.4% | 0.08% | +27.9% |
| Q1 2020 | $84,407,047,000 | +10.9% | 731,557 | +9.8% | 0.06% | +29.8% |
| Q4 2019 | $76,112,471,000 | +79.9% | 666,134 | +34.5% | 0.05% | +62.1% |
| Q3 2019 | $42,308,443,000 | +24.4% | 495,415 | +0.8% | 0.03% | +20.8% |
| Q2 2019 | $34,000,660,000 | -5.0% | 491,268 | +0.6% | 0.02% | -11.1% |
| Q1 2019 | $35,774,445,000 | -9.5% | 488,455 | -30.0% | 0.03% | -20.6% |
| Q4 2018 | $39,524,089,000 | -25.5% | 697,566 | +1.4% | 0.03% | -12.8% |
| Q3 2018 | $53,029,332,000 | +13.9% | 687,621 | -2.0% | 0.04% | +8.3% |
| Q2 2018 | $46,561,365,000 | +16.7% | 701,331 | -8.0% | 0.04% | +16.1% |
| Q1 2018 | $39,881,564,000 | +2.7% | 761,971 | +4.9% | 0.03% | -6.1% |
| Q4 2017 | $38,845,443,000 | +28.9% | 726,083 | +31.1% | 0.03% | +22.2% |
| Q3 2017 | $30,135,469,000 | +55.1% | 553,859 | +47.4% | 0.03% | +42.1% |
| Q2 2017 | $19,435,717,000 | +42.9% | 375,642 | +73.6% | 0.02% | +35.7% |
| Q1 2017 | $13,603,847,000 | +136498.5% | 216,415 | +14.7% | 0.01% | +27.3% |
| Q4 2016 | $9,959,000 | +119.1% | 188,705 | +124.3% | 0.01% | +120.0% |
| Q3 2016 | $4,545,000 | +32.1% | 84,148 | -1.2% | 0.01% | +25.0% |
| Q2 2016 | $3,441,000 | +19.6% | 85,148 | +3.9% | 0.00% | +33.3% |
| Q1 2016 | $2,876,000 | -28.0% | 81,948 | -7.9% | 0.00% | -40.0% |
| Q4 2015 | $3,993,000 | +22.1% | 88,991 | +4.9% | 0.01% | +25.0% |
| Q3 2015 | $3,271,000 | -85.9% | 84,831 | -82.3% | 0.00% | -81.8% |
| Q2 2015 | $23,166,000 | -42.8% | 478,643 | -58.3% | 0.02% | -43.6% |
| Q1 2015 | $40,532,000 | +39.0% | 1,146,593 | +26.3% | 0.04% | +39.3% |
| Q4 2014 | $29,164,000 | +5.0% | 907,697 | +21.5% | 0.03% | 0.0% |
| Q3 2014 | $27,773,000 | +392.1% | 746,997 | +406.2% | 0.03% | +366.7% |
| Q2 2014 | $5,644,000 | -20.2% | 147,568 | -4.9% | 0.01% | -25.0% |
| Q1 2014 | $7,069,000 | -3.1% | 155,163 | -15.1% | 0.01% | 0.0% |
| Q4 2013 | $7,294,000 | -36.3% | 182,862 | -30.0% | 0.01% | -42.9% |
| Q3 2013 | $11,448,000 | +43.2% | 261,190 | +2.8% | 0.01% | +40.0% |
| Q2 2013 | $7,993,000 | – | 254,058 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |